Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKD 1.66

(3.75%)

Operating Expenses Summary of Shanghai Bio-heart Biological Technology Co., Ltd.

  • Shanghai Bio-heart Biological Technology Co., Ltd.'s latest annual operating expenses in 2023 was 158.31 Million CNY , down -41.15% from previous year.
  • Shanghai Bio-heart Biological Technology Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 15.51 Million HKD , down -0.15% from previous quarter.
  • Shanghai Bio-heart Biological Technology Co., Ltd. reported a annual operating expenses of 269.02 Million CNY in annual operating expenses 2022, down -43.69% from previous year.
  • Shanghai Bio-heart Biological Technology Co., Ltd. reported a annual operating expenses of 477.76 Million CNY in annual operating expenses 2021, up 33.33% from previous year.
  • Shanghai Bio-heart Biological Technology Co., Ltd. reported a quarterly operating expenses of 15.51 Million HKD for 2024 Q2, down -0.15% from previous quarter.
  • Shanghai Bio-heart Biological Technology Co., Ltd. reported a quarterly operating expenses of 52.03 Million HKD for 2023 Q2, down -5.52% from previous quarter.

Annual Operating Expenses Chart of Shanghai Bio-heart Biological Technology Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of Shanghai Bio-heart Biological Technology Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 158.31 Million CNY -41.15%
2022 269.02 Million CNY -43.69%
2021 477.76 Million CNY 33.33%
2020 358.33 Million CNY 1698.21%
2019 19.92 Million HKD 0.0%

Peer Operating Expenses Comparison of Shanghai Bio-heart Biological Technology Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD 51.296%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 78.585%